Acetyl tetrapeptide-5
is used in cosmetic eye formulations to decrease puffiness, eye bags, and dark circles by reducing edema and protecting proteins such as SOD from glycation
Alanine
Ala / A · hydrophobic residue · neutral charge
AOD-9604
is studied as an anti-obesity peptide that can reduce weight gain and increase fat oxidation in obese animal models with generally neutral effects on IGF-1 and glucose metabolism in early human trials
Arginine
Arg / R · basic residue · positive charge
Argireline
is a topical cosmetic peptide reported to decrease dynamic wrinkles by partially mimicking the mechanism of botulinum toxin in a non-invasive manner
Asparagine
Asn / N · polar residue · neutral charge
Aspartic acid
Asp / D · acidic residue · negative charge
BPC-157
is investigated for accelerating healing of gastrointestinal mucosa, tendons, ligaments, bone, and nervous tissue in preclinical models, with anti-inflammatory and pro-angiogenic effects
Comparison
While Exenatide is used for type 2 diabetes treatment to improve glycemic control and modestly reduce body weight through GLP-1–like insulinotropic and glucagonostatic effects6768, MGF is upregulated in muscle after mechanical overload, where it supports tissue repair and growth; recombinant forms are studied for regenerative and performance-enhancement effects22138.
While Exenatide works as a 39-amino-acid exendin-4 peptide originally isolated from Gila monster venom that acts as a long-acting GLP-1 receptor agonist resistant to DPP-4 degradation67, MGF is a 24-amino-acid E-peptide splice variant of IGF-1 (IGF-1Ec) produced in mechanically stressed or damaged muscle that activates IGF1R and local anabolic pathways involved in muscle repair and hypertrophy22138144.
Exenatide
Not assigned in the current dataset.
MGF
IGF1
Exenatide and MGF are noticeably different, with limited direct overlap in their usual biological context. Their typical research and application settings separate fairly clearly: Exenatide is more often discussed in the realm of Metabolic and endocrine, whereas MGF is more often associated with the realm of Musculoskeletal health. Their biological logic is quite different: Exenatide is a receptor agonist, whereas MGF is a growth factor mimetic and a signaling modulator. Exenatide has a more venom-derived origin, while MGF is closer to natural endogenous background and their development context also differs, with Exenatide approved while MGF is in Preclinical development. Exenatide incorporates amidation features that are not part of MGF, while their sequence patterns also diverge, with Exenatide showing alpha-helical domain features and MGF showing protein-mimetic sequence features.